Cite

HARVARD Citation

    Alexander, G. et al. (2016). Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapy. Journal of hematology & oncology. 9 (1), pp. 1-7. [Online]. 
  
Back to record